Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Short Interest Down 99.2% in August

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the target of a large decrease in short interest during the month of August. As of August 31st, there was short interest totaling 1,200 shares, a decrease of 99.2% from the August 15th total of 155,400 shares. Based on an average trading volume of 455,700 shares, the days-to-cover ratio is currently 0.0 days. Based on an average trading volume of 455,700 shares, the days-to-cover ratio is currently 0.0 days.

Ono Pharmaceutical Stock Down 1.0%

Shares of OPHLY opened at $3.83 on Friday. Ono Pharmaceutical has a 52-week low of $3.21 and a 52-week high of $4.65. The stock has a 50 day moving average price of $3.73 and a 200 day moving average price of $3.68.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.